Tobacco Documents Online

TgMIS 449694

"The purpose of the 3rd World Conference on Smoking and Health is: to assess the trends in smoking around the world; to assess the meas- ures which have been employed to curb smok- ing and safeguard the health of the population from the hazards of smoking; and, then, to pro- pose ways to advance the effectiveness of these measures to the highest levels possible." 3rd World Conference on Smoking and Health Planning Committee September 27, 1973 TIMN 449695

3rd World Conference on Smoking and Health Sponsored by American Cancer Society National Cancer Institute (U.S.A.) In cooperation with: American Heart Association American Lung Association American Medical Association Health Education Council (UK) International Union Against Cancer National Cancer Institute of Canada National Clearinghouse for Smoking and Health (USA ) National Heart and Lung Institute ( USA ) National Interagency Council on Smoking and Health ( USA ) Pan American Health Organization World Health Organization Waldorf-Astoria Hotel New York City June 2-5,1975 TIMN 449696

3rd World Conference on Smoking and Health Chairman: Sir George E. Godber, G.C.B., D.M., F.R.C.P. Planning Committee Dr. David T. Carr, Chairman Dr. Mikhail A. Akhmeteli Dr. Stephen M. Ayres Dr. Sol R. Baker Dr. William Carlyon Dr. Charles M. Fletcher Mr. Emerson Foote Dr. Donald T. Fredrickson Dr. Gio B. Gori Dr. E. Cuyler Hammond Dr. Daniel Horn Mr. Walter G. James Dr. Daniel J. Joly Mr. Harry Milt, Coordinator Dr. Donald C. Kent Dr. Claude Lenfant Mr. Sol S. Lifson Dr. A. Helen Martikainen Dr. Alton Ochsner, Jr. Mr. Clifton Read Mr. Irving I. Rimer Mr. Roger W. Schmidt Dr. Jesse L. Steinfeld Dr. Robert M. Taylor Dr. Luther L. Terry Dr. A. P. Woudenberg Dr. Ernst L. Wynder 2

Conference Format The conference will begin 9:30 Monday morning, June 2, and end at noon Thursday, June 5. All sessions and functions will be held in the Waldorf Astoria Hotel. The conference will open in a plenary session for all par- ticipants, Monday morning, June 2. Monday afternoon, the conference will break into five separate sections, running concurrently and independ- ently, through Wednesday afternoon, June 4.: Section I-liealth Consequences of Smoking (p. 6) Section II -Modifying the Risk (p. 9) Section III-Education on Smoking (p. 12) Section IV-Cessation Programs (p. 16) Section V -Governmental and Social Action (p. 19) Thursday morning, June 5, the five sections will disband, and all participants will come together for the closing plenary session. Each participant has been asked to designate the section to which he or she would prefer to be assigned; also, to list second choices. In all but a very few cases, the first choice has been honored. TO AVOID CONFUSION AND DISORGANIZATION, CONFEREES ARE URGED TO REMAIN WITH THE SECTION TO WHICH THEY HAVE BEEN ASSIGNED: . In addition to the working sessions, there will also be two general functions: An informal reception, Monday evening, June 2. A luncheon Tuesday, June 3, at which the special guests will be the Advisory Committee to the Surgeon General, U.S. Public Health Service, and the Surgeon General, authors and sponsor of the historic report in 1964, SMOKING AND HEALTH. 3 TIMN 449698

3rd World Conference on Smoking and Health Opening Plenary Session 9:30 a.m., June 2 The Grand Ballroom Chairman: Sir George E. Godber, G.C.B., D.M., F.R.C.P. Call to order Opening address David T. Carr, M.D. Theodore Cooper, M.D. Assistant Secretary for Health, Department of Health, Education and Welfare Greetings Greetings Response Introduction of Cooperating Organizations Address: The Hazards of Smok- ing; The Benefits of Stopping- The Scientific Evidence to Date. Address: The Worldwide Cam- paign Against Smoking Address: Smoking and Health Conference Procedure Guy R. Newell, M.D. Deputy Director National Cancer Institute Lane W. Adams Executive Vice President American Cancer Society Alton Ochsner, M.D. By the Chairman Jesse L. Steinfeld, M.D. Sir George E. Godber Thomas Nesbitt, M.D. Speaker, House of Delegates American Medical Association David T. Carr, M.D. 5 TIMN 449699

Section I Health Consequences of Smoking This section will open with a general session Monday afternoon, June 2, in which review papers will be given on the effects of smoking in relation to cancer, pulmo- nary disease, cardiovascular disease, pregnancy, the pas- sive smoker, and the benefits of stopping. Tuesday morning, June 3, this section will divide into sub-sections. The sub-section on Smoking and Cancer will have ses- sions Tuesday morning and afternoon, June 3, and Wednesday morning, June 4. The sub-section on Smoking and Pulmonary Disease will have sessions Tuesday morning and Tuesday afternoon, June 3. The sub-section on Smoking and Cardiovascular Disease will have one session Wednesday morning, June 4. The sub-section on Smoking and Pregnancy will have one session Wednesday morning, June 4. There will be no separate sessions on the Benefits of Stopping or on the Passive Smoker. On Wednesday afternoon, June 4, the entire section on Health Consequences of Smoking will reconvene for evaluation, summary and recommendations. Thursday morning, June 5, all sections will come to- gether for the closing plenary session of the entire conference. Monday June 2 General Session: REVIEW OF RESEARCH 1:30 to 5:00 Chairman: Jesse L. Steinfeld Hilton Room 6 1. Consequences of Smoking: Cancer. E. Cuyler Ham- mond 2. Consequences of Smoking: Pulmonary Disease. Charles M. Fletcher 3. Consequences of Smoking: Cardiovascular Disease. Jeremiah Stamler 4. Consequences of Smoking: Pregnancy. Neville R. Butler 5. Consequences of Smoking: The Passive Smoker. David M. Burns 6. Benefits of Stopping: Daniel Horn TIMN 449700

TuesdayJune3 Sub-Section A: SMOKING AND CANCER 9:00 to 12:00 Chairman: E. Cuyler Hammond Hilton Room Studies on the Lung 1. Overview: Impact of smoking on the occurrence of " cancer. E. Cuyler Hammond 2. Japanese study: Smoking in relation to death rates from cancer. Takeshi Hirayama 3. Epidemiological evidence on relation between smok- ing habits and lung cancer. Marvin A. Schneiderman 4. Smoking in relation to histologic changes in bronchial epithelium. Oscar Auerbach 2:30 to 5:30 5. Cytological changes in relation to smoking. Geno Hilton Room Saccomanno • 6. Discussion of evidence on smoking and lung cancer. N. N. Napalkov Sites Other Than Lung 1. Smoking in relation to cancer of the mouth, tongue and lip. Condict Moore 2. Smoking in relation to cancer of pharynx, larynx, esophagus, bladder and other sites, except lung. Ernst L. Wynder Wednesday June 4 General and Theoretical 9:00 to 12:00 1. Multiple factor interaction. Irving J. Selikoff Hilton Room 2. Dosage factor (age began, amount, inhalation). E. Cuyler Hammond 3. Effects of giving up smoking. Lawre:pce Garfinkel 4. What additional information would., be useful. Panel: Gio B. Gori, Chairman TuesdayJune 3 Sub-Section B: SMOKING AND PULMONARY 9:00 to 12:00 DISEASE Basildon Room Chairman: Charles M. Fletcher 1. Smoking and lung function: epidemiological evidence. Benjamin G. Ferris 2. Smoking and lung function: laboratory evidence. D. V. Bates 3. Smoking and bronchial clearance. Michael T. New- house 2:30 to 5:30 Chairman: Oscar Auerbach Basildon Room 4. Experimental and human pathology (pulmonary) in relation to smoking. Oscar Auerbach 5. Acute and chronic smoking inhalation studies in rats. Paul Nettesheim 6. Evidence for pre-clinical lesions in lungs of early smokers. Jerome I. Kleinerman 7 TIMN 449701

Wednesday June 4 9:00 to 12:00 Starlight Roof North Terrace Wednesday June 4 9:00 to 12:00 Starlight Roof South Terrace Sub-Section C: SMOKING AND CARDIOVASCULAR DISEASE Chairman: Jeremiah Stamler 1. Epidemiological studies in the United States on smok- ing and coronary heart disease. Jeremiah Stamler 2. Epidemiological studies in the United Kingdom on smoking and coronary heart disease. Donald D. Reid 3. Studies in Scandinavia and Western European coun- tries. Lars Wilhelmsen 4. Studies in Poland and other Eastern European coun- tries. Kornel Gibinski 5. Studies in Japan. Noboru Kimura 6. Epidemiological studies on smoking and cerebral vas- cular and peripheral disease. William B. Kannel 7. Studies on carbon monoxide, thiocyanide and nico- tine. Poul Astrup Sub-Section D: SMOKING AND PREGNANCY Chairman: Neville R. Butler 1. Epidemiological considerations. Neville R. Butler 2. Intrauterine studies-effect on fetal breathing. Geof- frey S. Dawes 3. Statistical aspects. Harvey Goldstein 4. Physiological studies. Lawrence D. Longo Wednesday June 4 General Session, Section 1: EVALUATION AND 2:00 to 5:00 SUMMARY Chairman: Jesse L. Steinfeld Thursday June 5 9:00 to 12:00 Empire Room 8 1. Benefits of stopping. Leonard M. Schuman 2. Health consequences: cancer. E. Cuyler Hammond 3. Health consequences: pulmonary. Charles M. Fletcher 4. Health consequences: cardiovascular. Jeremiah Stam- ler 5. Health consequences: pregnancy. Neville R. Butler Closing Plenary Session for the Entire Conference Chairman: Sir George E. Godber Report of recommendation from each of the five sections and adoption of recommendations. , TIMN 449702

Section tl Modifying The Risk To The Smoker This section will open with a general session on Monday afternoon, June 2 in which there will be reports and dis- cussion of general problems and opportunities related to the less harmful cigarette. Tuesday morning and afternoon, June 3, there will be three sub-sections running concurrently, with reports and discussion on the ways in which the particular ingredients of tobacco smoke are related to disease in different or- gans and systems: cancer, cardiovascular disease, and chronic pulmonary disease. Wednesday morning, June 4, the section will reassemble in general session for reports and discussion on the tech- nolbgical aspects of our ability to reduce specific com- ponents of cigarette smoke; also the factor of public acceptance of these reductions. Wednesday afternoon, June 4, the section will meet again in general session to hear and discuss recommendations on modifying the risk. Thursday morning, June 5, all sections will come together for the closing plenary session of the entire conference. Monday June 2 General Session: PROBLEMS AND 1:30 to 5:30 OPPORTUNITIES Jade Room Chairman: Ernst L. Wynder 1. Relative risks of cigarette-related disease by type of cigarette smoked. Ernst L. Wynder 2. The physiochemical nature of tobacco smoke. Irwin Schmeltz 3. Methods for reduction of tar and nicotine levels in tobacco and in cigarettes. a. Agricultural techniques. T. C. Tso b. Filtration techniques. Charles M. Keith c. Tobacco modifications. Howard M. Halter d. Tobacco modifications. Bryan F. Zilkey e. Particle size. Friedlieb Seehofer. f. Reconstituted sheets. William A. Selke 4. Reduction of tar and nicotine levels in different coun- tries during the last two decades. a. U.S.A. Thomas B. Owen b. United Kingdom. Donald D. Reid c. Germany. Dietrich Schmahl d. Austria. Hans Kuhn e. Sweden. Lasse O. Hjern f. Canada. Winston H. Cherry 5. Less harmful ways of smoking. (Risk related to cigar/ pipe smoking, inhalation, butt end, etc.). a. Epidemiological data. Irwin D. Bross 9 TIMN 449703

Tuesday June 3 Sub-Section A: RELATION OF SMOKE 9:00 to 12:00 COMPONENTS TO CANCER Vertes Suite "U" (Including cancers of the upper alimentary tract, larynx, lung and bladder.) Co-Chairmen: Dietrich K. Hoffman, Gio B. Gori l. Methodology for determining the possible beneficial effects of the less harmful cigarette on the risk for cancer. Lawrence Garfinkel 2. Chemical identification in tobacco smoke of (a) car- cinogens, (b) promoters, (c) co-carcinogens. Dietrich K. Hoffman Discussion: Hans P. Harke, Michael R. Guerin 3. Chemical and biological identification of tumorigenic components of tobacco. Fred G. Bock Discussion: Stephen S. Hecht, D. Bhaskara Reddy Tuesday June 3 4. Biological evaluation of carcinogens in tobacco smoke. 2:30 to 5:30 Walter Dontenwill Vertes Suite "U" Discussion: Gio B. Gori, Robert Maronpot r 5. Chemical and biological evaluation of tobacco sub- stitutes. Roland K. Kunkel Discussion: David M. Conning 6. Summation: Relative significance of various tobacco smoke components in the etiology of cancer. Benjamin L. Van Duuren Tuesday June 3 Sub-Section B: RELATION OF SMOKE 9:00 to 12:00 COMPONENTS TO Vertes Suite "V" CARDIOVASCULAR DISEASE Co-Chairmen: Gardner C. McMillan, Wilbert S. Aronow 1. Methodology for determining the possible beneficial effects of the less harmful cigarette on the risk for cardiovascular disease. Tavia Gordon 2. Relative risks for myocardial infarction, cardiovascu- . lar disease and peripheral vascular disease by smok- ing and type of smoking. Manning Feinleib Discussion: Leo K. Widmer 3. The interrelationship of tobacco smoke components to hyperlipidemia and other risk factors in cardiovas- cular disease. Thomas R. Dawber Discussion: Oglesby Paul Tuesday June 3 4. The evidence for nicotine as an etiological factor. 2:30 to 5:30 Helmut Schievelbein Vertes Suite "V" Discussion: Egbert Niissel, Henry C. McGill, Jr., Peter Hill 5. The evidence for carbon monoxide as an etiological factor. Wilbert S. Aronow Discussion: Poul Astrup, Keith P. Ball, Nicholas Wald. 6. The evidence for other components as etiological fac- tors. Gardner C. McMillan 7. Summation: Relative significance of nicotine, CO and other smoke components in the etiology of cardiovas- 10 cular disease. William B. Kannel TIMN 449704

Tuesday June 3 9:00 to 12:00 Terrace Court 2:30 to 5:30 Terrace Court Wednesday June 4 9:00 to 12:00 Jade Room SVednesday June 4 2:00 to 5:00 Jade Room Thursday June 5 9:00 to 12:00 Empire Room Sub-Section C: RELATION OF SMOKE COMPONENTS TO CHRONIC PULMONARY DISEASE Co-Chairmen: Claude Lenfant, Walter W. Holland 1. Methodology for determining the possible beneficial effects of the less harmful cigarette on the risk for em- physema and,:'or chronic bronchitis. Walter W. Hol- land 2. Relative risks of various tobacco usages for emphy- sema and, 'or chronic bronchitis. Ian T. Higgins Discussion: Theodor Abelin 3. Interrelation of tobacco smoke to other respiratory irritants with respect to lung cancer, emphysema and chronic bronchitis. Irving J. Selikoff 4. Etiological factors (particulate matter or volatile phase). Tore Dalhamn Discussion: Charles M. Fletcher, Ragnar Rylander, Charles J. Kensler, Louis Diamond 5. Summation: Relative significance of various tobacco smoke components in the etiology of emphysema and/ or chronic bronchitis. John P. Wyatt General Session: TECHNOLOGICAL ASPECTS OF REDUCING SPECIFIC COMPO- NENTS IN CIGARETTE SMOKE, AND CONSUMER ACCEPTANCE OF SUCH REDUCTION Co-Chairmen: T. C. Tso, Hans Kuhn 1. Methods for tar and nicotine determination-an inter- national comparison. Klaus Brunnemann 2. Total particulate matter. Gio B. Gori 3. Nicotine. Hans Kuhn 4. PAH. Dietrich K. Hoffman 5. Carbon monoxide. Donald Tiggelbeck 6. Phenolic components. Charles J. Kensler 7. Cilia toxic components. Sam P. Battista 8. Nitrosamines. Stephen S. Hecht 9. Other (i.e. NO., B-naphthalamine, etc.). Fred G. Bock General Session, Section 11: SUMMARY AND REC- OMMENDATIONS Chairman: Ernst L. Wynder Closing Plenary Session for the Entire Conference Chairman: Sir George E. Godber Report of recommendations from each of the five sections and adoption of recommendations. 11 ,rIMN 449705

Section III Education On Smoking This section will open with a general session Monday afternoon June 2 and will hear status reports on educa- tion on smoking with respect to (a) adults, (b) school-age children, (c) mass media, (d) professional groups. Starting Tuesday morning, June 3, and continuing through Wednesday afternoon, June 4, this section will break down into four parallel sub-sections running simultaneously. The full section will reconvene in general meeting the latter part of Wednesday afternoon June 4 to consider recommendations. Thursday morning, June 5, all sections will come to- gether for the closing plenary session of the entire con- ference. Monday June 2 1:30 to 5i00 John Jacob Astor Salon Tuesday June 3 9:00 to 12:00 Gold Room 12 General Session: STATUS REPORTS ON DIFFERENT ASPECTS OF EDUCATION ON SMOKING Chairman: William Griffiths 1. Changing the smoking habits of adults. Norman K. McAbee, Jr. 2. Positive smoking, education programs for the school age child. Roy L. Davis 3. The mass media anti-smoking campaign around the world. Paula Green 4. The role of the health professional in smoking educa- tion. Tage Egsmose 5. Charge to the workshops. Walter G. James Sub-Section A: PROGRAMS FOR ADULTS Chairman: Bratislav Tomic 1. Charge to the Adult Program Group. Charles A. Althafer 2. Smoking control programs aimed at adult audiences. a. United Kingdom and Europe. William S. Parker b. Canada. Alexander J. Phillips c. Industrial populations. H. Wayne Richmond d. Involving the adult community in hospital smoking education programs. Glenn I. Hildebrand e. Public utilization of medical tape libraries. Richard O. Butcher TIMN 449706

Tuesday June 3 2:30 to 5:30 Gold Room Wednesday June 4 9:00 to 12:00 Gold Room WOMEN AND CIGARETTES Chairman: Helen S. Hill a. Chronic disease aspects of cigarette smoking in the U.S. Cheryl Cortines b. Profile of women's smoking habits in Canada and the United Kingdom. Gwen W. Rorke c. Profile of women's smoking habits in Western Eu- rope. Annette Le Meitour-Kaplun d. Reactor panel: Frances Driscoll, James B. Losie, Nancy B. Ringle NON-SMOKERS RIGHTS Chairman: Owen D. Lewis a. Smoke constituents. David M. Burns b. The cardio-pulmonary cripple. Charles Tate c. Allergies and eyes. Norman Epstein d. The U. S. experience. Roger W. Schmidt e. Social action. Clare Gouin f. Filtration and ventilation of tobacco smoke. Donald C. Kent g. Legal rights of the non-smoker. Glenn R. Goldberg h. Reactor panel. George L. Stewart, Jan Stephens Wednesday June 4 1:30 to 3:15 Gold Room Tuesday June 3 9:00 to 12:00 Louis XVI East Formulation of Recommendations by Sub-Section A Sub-Section B: PROGRAMS FOR SCHOOL-AGE CHILDREN Chairman: Stephen M. Ayres 1. The smoking habits of youth: 1967, 1971, 1975. Pres- ent trends. Dorothy E. Green 2. Social influences that affect children and youth. Evert Dekker 3. Intervening in social systems to make smoking educa- tion more effective. Lawrence W. Green 4. Charge to the workshops. Sol S. Lifson Tuesday June 3 2:30 to 5:30 Workshop: PROGRAMS FOR SCHOOL-AGE CHILDREN Louis XVI East There are no assigned papers, but discussion will cover these subjects: a. What can be done to improve school curriculum with respect to anti-smoking content. b. What can be done to have teachers better prepared in health education related to smoking. c. What can schools do to influence the community regarding attitudes and practices in smoking. d. What happened to the recommendations of the 1st and 2nd World Conferences on Smoking. 3 TININ 449707

Wednesday June 4 9:00 to 12:00 Louis XVI East Wednesday June 4 1:30 to 3:15 Louis XVI East Tuesday June 3 9:00 to 12:00 Louis XVI Center Tuesday June 3 2:30 to 5:30 Louis XVI Center Wednesday June 4 9:00 to 12:00 Louis XVI Center Wednesday June 4 1:30 to 3:15 Louis XVI Center 14 Workshop: PROGRAMS FOR SCHOOL-AGE CHILDREN (Continued) Formulation of Recommendations by Sub-Section B Sub-Section C: MASS MEDIA Chairman: Emerson Foote 1. Women and Smoking in England. Alastair C. Mackie 2. Women and Smoking in America. Mary Loos 3. The Australian Television Anti-Smoking Campaign. Nigel Gray 4. D-Day in Minnesota. Lynn R. Smith 5. The FCC and Cigarette Advertising. C. D. Roberts 6. How to Get Smokers to Listen, Tony Schwartz 7. Mass Media Experience in Canada. F. R. Wake Workshop: MASS MEDIA Workshop: MASS MEDIA (Continued) Formulation of Recommendations by Sub-Section C TIMN 449708

Tuesday June 3 9:00 to 12:00 Louis XVI West Tuesday June 3 2:30 to 5:30 Louis XVI West Wednesday June 4 9:00 to 12:00 Louis XVI West Wednesday June 4 1:30 to 3:15 Louis XVI West Wednesday June 4 3:30 to 5:00 John Jacob Astor Salon Thursday June 5 9:00 to 12:00 Empire Room Sub-Section D: HEALTH PROFESSIONALS Chairman: Eivind Toft-Nielsen 1. Health professionals as educators. Alfred Yarrow 2. The exemplar role of professionals. Joanne B. Lager- son 3. Prohibiting smoking in professional areas. Generoso F. Basa 4. Working with professional groups to increase priori- ties in smoking education. Theodor Abelin 5. Charge to the workshops. Irene G. Hiscock Workshops: HEALTH PROFESSIONALS 1. Educators: Cynthia L. Hull 2. Exemplars: B. G. Loveless 3. Environment: George T. Harrell Success and Failure Stories on: -persuading health professionals to modify their own smoking habits. -altering institutional policies. -health professionals as personal health educators. Formulation of Recommendations by Sub-Section D General Session, Section 111: FORMULATION OF RECOMMENDATIONS Chairman: William Griffiths Closing Plenary Session for the Entire Conference Chairman: Sir George E. Godber Report of recommendations from each of the five sections and adoption of recommendations. 15 TIMN 449709

Section IV Cessation Activities This section will open with a general session Monday afternoon, June 2, to hear status reports on cessation methods: (a) behavior therapy, (b) hypnosis, (c) pharma- cologic intervention, (d) physician intervention and per- sonal health counseling, and (e) public education. The status report on smoking withdrawal clinics is dealt with separately, Wednesday afternoon, June 4. Tuesday morning, June 3, the section will break into four separate workshops: (a) behavior therapy, (b) pharma- cologic intervention, (c) public education, and (d) a com- bined workshop for physician intervention, personal health counseling and hypnosis. Tuesday afternoon, June 3, the entire section will recon- vene for a general session-a symposium on the difficul- ties people have in giving up smoking. Wednesday morning, June 4, the section will break again, this time into three symposia: (a) research methodology, (b) guidelines for organizing smoking withdrawal clinics, (c) conference recommendations. Wednesday afternoon, June 4, the section will reconvene in general session to consider recommendations. Thursday morning, June 5, all sections will come together for the closing plenary session of the entire conference. Monday June 2 General Session: STATUS REPORTS ON 1:30 to 5:00 CESSATION METHODS Basildon Room Chairman: Keith P. Ball 1. Behavior Therapy. Edward Lichtenstein 2. Hypnosis. Martin T. Orne 3. Pharmacologic Intervention. Murray E. Jarvik 4. Physician Intervention and Personal Health Counsel- ing. Geoffrey Rose 5. Public Education. Lars M. Ramstrom 6. Smoking Withdrawal Clinics (see Wednesday after- noon) 16 TIMN 449710

Tuesday June 3 9:00 to 12:00 Duke of Windsor Suite Tuesday June 3 9:00 to 12:00 Vanderbilt Suite Tuesday June 3 9:00 to 12:00 Conrad's Salon Tuesday June 3 9:00 to 12:00 Conrad's Dining Room Tuesday June 3 2:30 to 5:30 John Jacob Astor Salon Wednesday June 4 9:00 to 12:00 Conrad's Salon Wednesday June 4 9:00 to 12:00 Conrad's Dining Room Wednesday June 4 9:00 to 12:00 Basildon Room Workshop A: BEHAVIOR THERAPY Chairman: Edward Lichtenstein Panel: Johannes C. Brengelmann, Joseph E. Cautela, Steven A. Kopel Workshop B: PHARMACOLOGIC INTERVENTION Chairman: Murray E. Jarvik Panel: Bo Brantmark, Borje E. Ejrup, Jane F. Emele, Ove B. Ferno, Ellen R. Gritz, Ian P. Stolerman Workshop C: PUBLIC EDUCATION Chairman: Lars M. Ramstrom Panel: Rosmarie Erben, Gisela A. Gastrin Workshop D: PHYSICIAN INTERVENTION, PERSONAL HEALTH COUNSELING, HYPNOSIS Chairmen: Geoffrey Rose, Martin T. Orne Panel: Herbert Spiegel, S. Leonard Syme, Richarl W. Turner, Lars Wilhelmsen General Session: PANEL DISCUSSION Why Do So Many People Have So Much Difficulty Giv- ing Up Smoking and What Can We Do About It? Chairman: Daniel Horn Panel: Jerome H. Jaffe, Bernard Mausner, M. A. H. Russell Symposium A: RESEARCH METHODOLOGY IN SMOKING CESSATION Chairman: Douglas A. Bernstein Panel: William A. Hunt, Ovide F. Pomerleau, Jerome L. Schwartz, Bruce C. Straits Symposium B: GUIDELINES FOR ORGANIZING SMOKING WITHDRAWAL CLINICS Chairman: Lloyd A. Shewchuk Panel: Johannes C. Brengelmann, Dee Burton, G. Craig Caputo, Laura Karenen, Boris Luban-PIozza Symposium C: COMMITTEE ON CONFERENCE RECOMMENDATIONS Chairman: Donald T. Fredrickson Panel: Joseph Chadwick, Paul M. Insel, Alan S. Meyer, George Saunders, Jerome L. Schwartz 17 TIMN 449711

GENERAL SESSION Wednesday June 4 1. Status Report on Smoking Cessation Clinics 1:30 to 3:15 Chairman: Branko Kesic Basildon Room Wednesday June 4 3:30 to 5:00 Basildon Room a. Report on U.S. and Canada. Jerome L. Schwartz b. Report on Europe, Asia, South America: Else-Lill Berglund 2. An Integrated A pproach to Smoking Control Chairman: Gosta Tibblin Panel: Joseph Chadwick, Lars Wilhelmsen, Peter D. Wood, Alfred McAlister Thursday June 5 Closing Plenary Session for the Entire Conference 9:00 to 12:00 Chairman: Sir George E. Godber Empire Room Report of recommendations from each of the five sections and adoption of recommendations. 18 TIMN 449712

Section V Governmental and Social Action This section will open with a general session, Monday afternoon, June 2, to hear reports on governmental and social action around the world. There will be no breakdown into separate sub-sections. This group will remain together in general session Mon- day afternoon, June 2, all day Tuesday, June 3, and all day Wednesday, June 4. Tuesday morning and afternoon, June 3, there will be reports and discussion on special approaches to the control of smoking. Wednesday morning, June 4, there will be reports and discussion on organizing for action at the international, regional, national and voluntary organization levels. The session on organizing for action will continue part way into the Wednesday afternoon session. During the latter part of that session (Wednesday after- noon, June 4), recommendations for future action will be considered and adopted. Thursday morning, June 5, all sections will come to- gether for the closing plenary session of the conference. Monday June 2 General Session: GOVERNMENTAL AND SOCIAL 1:30 to 5:00 ACTION AROUND THE WORLD Empire Room Chairman: Robert M. Taylor 1. Survey of legislative action by governments around the world. Jean De Moerloose 2. Survey of educational programs on smoking in Eu- rope. Wolfgang E. Fritsche 3. Anti-smoking programs in several countries a. Austria. Michael Kunze b. Switzerland. Meinrad E. Schar c. England. Jack B. Cornish d. Poland. Kornel Gibinski e. Sweden. Gosta Tibblin f. United States. Michael Pertschuk g. U.S.S.R. D. Loransky h. Yugoslavia. Djordje Jakovljevic 19 TIMN 449713

Tuesday June 3 9:00 to 12:00 Empire Room Tuesday June 3 2:30 to 5:30 Empire Room 20 General Session: SPECIAL APPROACHES TO THE CONTROL OF SMOKING (i) Chairman: Carl E. Sturkell 1. Phasing out tobacco a. The economic and political aspects of phasing out tobacco. Leo A. Kaprio, b. The effects on a tobacco-dependent economy. Vladimir Kalaydjiev, 2. "Pricing out" tobacco a. Price as a factor in cigarette consumption. Robert H. Miller, 3. Prohibition of Advertising a. The effect of the advertising ban on consumption. James L. Hamilton b. Some problems in phasing out advertising. Michael M. Daube c. Should advertising be banned? Karl R. Waernberg, Anders Bratholm General Session: SPECIAL APPROACHES TO THE CONTROL OF SMOKING (11) Chairman: Luther L. Terry 1. Reducing tar, nicotine and CO levels in cigarettes a. Methods for reducing tar, nicotine and CO levels in cigarettes; experiences in reducing these compo- nents in different countries. Gio B. Gori b. Taxing cigarettes according to tar content. William Drayton 2. Cessation Programs a. Status of cessation programs around the world. Jerome L. Schwartz 3. Restriction on Smoking in Public Places a. Health hazards to the passive smoker. Scientific evi- dence. Wilbert S. Aronow, b. Governmental and social action to restrict smoking. John F. Banzhaf III. TIMN 449714

Wednesday June 4 9:00 to 12:00 Empire Room Wednesday June 4 1:30 to 2:30 Empire Room 2:45 to 5:15 Empire Room Thursday June 5 9:00 to 12:00 Empire Room General Session: ORGANIZING FOR ACTION Chairman: Kjell Bjartveit 1. The Expert Committee of WHO; a report. Mikhail A. Akhmeteli 2. The Nordic Council; a report. K. Olavi Elo 3. Organizing for action in Latin America; a proposal. Daniel J. Joly 4. Special Government Agencies a. The National Council on Smoking and Health, Nor- way. Kjell Bjartveit b. The Health Education Council, U.K. Arthur J. Dalzell-Ward 5. Voluntary Organizations a. The role and performance of the voluntary organi- zation in control of smoking. Nigel Gray b. Panel: (1) American Cancer Society: Allan K. Jonas (2) ASH, England: Michael M. Daube (3) Israel Cancer Association: Dov B. Ben-Meir (4) National Association on Smoking and Health, Norway: Allan Aarflot (5) National Interagency Council on Smoking and Health (U.S.A.): Roger W. Schmidt (6) World Conference of 7th Day Adventists: J. Wayne McFarland General Session 1. Voluntary organizations (continued from morning session) 2. General Session: RECOMMENDATIONS ON GOVERNMENTAL AND SOCIAL ACTION Chairman: Robert M. Taylor a. Governmental programs. Fritz Beske b. Motivating governments to act. Berit As c. Adoption of recommendations. Closing Plenary Session for the Entire Conference Chairman: Sir George E. Godber Report of recommendations from each of the five sections and adoption of recommendations. 21 TIMN 449715

Program Participants Allan Aarflot Editor TOBAKKEN OG VI Oslo, Norway Theodor Abelin, M.D. Professor; Head, Department of Social and Preventive Medicine University of Berne Berne, Switzerland Mikhail A. Akhmeteli (Candidate of Medical Sciences, USSR) Director, Division Non-Communicable Diseases World Health Organization Geneva, Switzerland Charles A. Althafer, M.P.H. Acting Director National Clearinghouse for Smoking and Health Atlanta, Georgia Wilbert S. Aronow, M.D. Chief, Cardiology Section Veterans Administration Hospital Long Beach, California 0 Berit S. As, M.P. Parliament, The Norwegian Government Oslo, Norway Poul Astrup, M.D. Professor Dept. of Clinical Chemistry Rigshospitalet Copenhagen, Denmark Oscar Auerbach, M.D. Senior Medical Investigator Veterans Administration Hospital East Orange, New Jersey Stephen M. Ayres, M.D. Physician-in-Chief The Saint Vincent Hospital Worcester, Massachusetts Sol R. Baker, M.D. Assoc. Clinical Professor, Therapeutic Radiology UCLA School of Medicine Beverly Hills, California Keith Ball, M.D., F.R.C.P. Cardiologist & Physician Central Middlesex Hospital London, England John F. Banzhaf III Executive Director Action on Smoking and Health Washington, D.C. Generoso F. Basa, M.D. Executive Secretary Philippine Cancer Society, Inc. Manila, Philippine Islands 22 D. V. Bates, M.D. Faculty of Medicine University of British Columbia Vancouver, Canada Sam P. Battista, Ph.D. Senior Staff Pharmacologist Arthur D. Little, Inc. Cambridge, Massachusetts Dov B. Ben-Meir Director General Israel Cancer Association Tel-Aviv, Israel Else-Lill Berglund, Dr.H.Sc. Consultant National Council on Smoking and Health Oslo, Norway Douglas A. Bernstein, Ph.D. Associate Professor, Department of Psychology Western Washington State College Bellingham, Washington Fritz Beske, M.D. Secretary of State Ministry for Social Affairs of Schleswig-Holstein Kiel Germany (Federal Republic of Germany) Kjell Bjartveit, M.D., D.P.H. Chairman of Council The National Council on Smoking and Health Oslo, Norway Fred G. Bock, Ph.D. Director, Orchard Park Laboratories Roswell Park Memorial Institute Buffalo, New York Bo Brantmark, Ph.D. Assistant Head Medical Department Aktiebolaget Leo Helsingborg, Sweden Anders Bratholm, LL.D. Professor of Law University of Oslo Oslo, Norway Johannes C. Brengelmann, M.D., Ph.D. Head, Department of Psychology Max-Planck-Institute for Psychiatry Munich, Germany Irwin D. J. Bross, Ph.D. Director of Biostatistics Roswell Park Memorial Institute Buffalo, New York Klaus Brunnemahn Head, Section of Analytical Chemistry American Health Foundation Naylor Dana Institute for Disease Prevention Valhalla, New York TIMN 449716

WaIter J. Burdette, M.D., Ph.D. Houston, Texas David M. Burns; M.D. Medical Officer National Clearinghouse for Smoking and Health' Center for Disease Control Atlanta, Georgia Dee Burton Therapist American Health Foundation New York, New York Richard O. Butcher, M.D. San Diego, California Neville R. Butler, M.D., F.R.C.P., D.C.H. Professor of Child Health, University of Bristol Department of Child Health Royal Hospital for Sick Children Bristol, England G. Craig Caputo, Ph.D. Research Associate Department of Psychology University of Wisconsin Madison, Wisconsin William Carlyon, Ph.D. Assistant Director Department-Health Education American Medical Association Chicago, Illinois David T. Carr, M.D. Chairman, Dept. of Oncology Mayo Clinic Rochester, Minnesota Joseph R. Cautela, Ph.D. Professor of Psychology Psychology Department Boston College Chestnut Hill, Massachusetts Joseph Chadwick, Ph.D. Director of Health Systems Program Menlo Park, California Dr. Winston H. Cherry Department of Statistics University of Waterloo Waterloo, Ontario, Canada William G. Cochran, M.A. Department of Statistics Science Center Harvard University Cambridge, Massachusetts David M. Conning, M.B., B.S. Deputy Director Imperial Chemical Industries Limited Central Toxicology Laboratory Alderley Park Cheshire, England Theodore Cooper, M.D. Assistant Secretary for Health Department of Health Education and Welfare Washington, D.C. Jack B. Cornish Department of Health and Social Security London, England Cheryl Cortines, M.P.H. Health Education Consultant Cancer and Heart Disease Program Texas State Department of Health Austin, Texas Tore Dalhamn, M.D. Institutionen for Hygien Bromedicinska Antrum Uppsala, Sweden Arthur J. Dalzell-Ward, FFCM, DPH Chief Medical Officer The Health Education Council London, England Michael M. Daube Executive Director ASH (Action on Smoking and Health) London, England Roy L. Davis, M.A., M.P.H. Director, Community Program Development Center for Disease Control Atlanta, Georgia Thomas R. Dawber, M.D. Professor of Medicine Boston University, School of Medicine Boston, Massachusetts Geoffrey S. Dawes, D.M., F.R.S. Professor, Director of Nuffield Institute for Medical Research University of Oxford Oxford, England Jean De Moerloose, M.D. Chief, Health Legislation World Health Organization Geneva, Switzerland Evert Dekker, Ph.D. Head, Dept. of Mental Hygiene Ministry of Public Health and Environmental Hygiene Leidschendam, Netherlands Louis Diamond, Ph.D. Director, Pharmacodynamics and Toxicology Division University of Kentucky College of Pharmacy Lexington, Kentucky Dr. Walter pontenwill Director, Research Institute of the German Cigarette Industry Hamburg, Germany 23 ,y1MN 449717

William Drayton, M.A., J.D. Lawyers' Committee on Tax Reform New York, New York Frances M. Driscoll, M.A. Adult and Youth Coordinator Rhode Island Interagency Council on Smoking Pawtucket, Rhode Island Tage Egsmose, M.D. Y Associate Professor Copenhagen University Institute of Hygiene Copenhagen, Denmark Borge E. V. Ejrup, M.D. Clinical Associate Professor of Medicine Cornell University Medical College New York, New York K. Olavi Elo, M.D., D.P.H. Acting Director, Department of Epidemiology and Hygiene National Board of Health Helsinki, Finland Jane Frances Emele, Ph.D. Director of Biological Research American Chicle Division of Warner Lambert Company Morris Plains, New Jersey Norman Epstein, M.D., C.M., F.R.C.P.(C), F.A.C.A. St. Joseph's Hospital Toronto, Canada Rosmarie Erben Psychologist, Governmental Consultant Federal Center for Health Education Koln-Me'rheim, Germany Emanuel Farber, M.D. Temple University School of Medicine Fels Research Institute Philadelphia, Pennsylvania Manning Feinleib, M.D., D.P.H. Chief, Epidemiology Branch Division of Heart and Vascular Disease National Heart and Lung Institute Bethesda, Maryland Dr. Ove B. Ferno Vice President Aktiebolaget Leo Helsingborg, Sweden Benjamin G. Ferris, M.D., F.A.C.P.M. Professor, Environmental Health and Safety Harvard School-of Public Health Boston, Massachusetts Charles M. Fletcher, C.B.E., M.D. Professor of Clinical Epidemiology Department of Medicine, Royal Postgraduate Medical School Hammersmith Hospital London, England 24 Emerson Foote Honorary Life Member American Cancer Society New York, New York Donald T. Fredrickson, M.D. Director, Inter Society Commission for Heart Disease Resources New York, New York * Jacob Furth, M.D., Sc.D. Emeritus Professor of Pathology Institute of Cancer Research Francis Delafield Hospital Columbia University College of Physicians & Surgeons New York, New York Lawrence Garfinkel, M.A. Assistant Vice President Epidemiology and Statistics American Cancer Society New York, New York Gisela A. Gastrin, M.D. Specialist in Health Education Helsinki, Finland Kornel Gibinski, M.D. Director Institute of Internal Medicine Slaskiej Academy of Medicine Katowice, Poland Sir George E. Godber, G.C.B., D.M., F.R.C.P. Chairman, Expert Committee on Smoking and Health World Health Organization and formerly Chief Medical Officer Dept. of Health and Social Security United Kingdom Glenn A. Goldberg, J.D. General Counsel Action on Smoking and Health (ASH) Washington, D.C. Harvey Goldstein, B.Sc. Head of Statistics National Children's Bureau London, England Tavia Gordon Statistician National Heart and Lung Institute Bethesda, Maryland Gio B. Gori, Ph.D. Deputy Director, Division of Cancer Cause and Prevention National Cancer Institute Bethesda, Maryland *Dr. Wolfgang E. Fritsche President, Federal Center for Health Education Cologne, Germany 7CIlVI~T 449718

Clara L. Gouin, M.A. Founder - Group Against Smokers' Pollution (GASP) College Park, Maryland Nigel J. Gray, M.B., B.S., F.R.A.C_P., F.A.C.M.A. Director Anti-Cancer Council of Victoria East Melbourne, Australia Dorothy E. Green, Ph.D. Consulting Research Psychologist Arlington, Virginia Lawrence W. Green, D.P.H. Head, Division of Health Education School of Hygiene & Public Health Johns Hopkins University Baltimore, Maryland Paula Green President Green Dolmatch Inc. Advertising New York, New York William Griffiths, Ph.D. Professor of Public Health and Chairman, Dept. of Social & Admin. Health Sciences University of California School of Public Health Berkeley, California Ellen R. Gritz, Ph.D. Research Psychologist Veterans Administration Hospital Brentwood Los Angeles, California Michael R. Guerin, Ph.D. Group Leader, BiolOrganic Analysis Oak Ridge National Laboratory Oak Ridge, Tennessee Howard M. Halter, M.S. Vice President and Director of Research and Development AMF Inc. Richmond, Virginia James L. Hamilton, Ph.D. Associate Professor of Economics Wayne State University Detroit, Michigan E. Cuyler Hammond, Sc.D. Vice President - Epidemiology & Statistics American Cancer Society, Inc. New York, New York Nathan C. Hanson, M.S. Program Director American Heart Association-Ohio Affiliate Columbus, Ohio Hans P. Harke, Ph.D. Forschungsinstitut der Cigarettenindustrie e. V. Hamburg Germany George T. Harrell, M.D. Vice President for Medical Sciences Emeritus The Milton S. Hershey Medical Center The Pennsylvania State University Timonium, Maryland Stephen S. Hecht, Ph.D. Associate Member American Health Foundation Valhalla, New York Ian T. T. Higgins, M.D., F.R.C.P. Professor of Epidemiology, School of Public Health University of Michigan Ann Arbor, Michigan Glenn I. Hildebrand, M.P.H. Education Director California Division, American Cancer Society San Francisco, California Mrs. Helen S. Hill Texas State Department of Health Austin, Texas Peter Hill, Ph.D. Head Lipid Metabolism American Health Foundation Valhalla, New York Takeshi Hirayama, M.D., Dr. M.Sc., M.P.H. Chief Epidemiology Division National Cancer Center Research Institute Tokyo Japan Irene Gilbert Hiscock Los Angeles, California Lasse O. Hjern, M.Sc. Head, Central Laboratory Swedish Tobacco Company Stockholm Sweden Dietrich K. Hoffman, Ph.D. Chief, Division EnvironmentaLCarcinogenesis Naylor Dana Institute for Disease Prevention Valhalla, New York Walter W. Holland, M.D., F.R.C.P., F.F.C.M. Professor of Clinical Epidemiology and Social Medicine Department of Community Medicine, St. Thomas's Hospital Medical School London England 25 TIMN 449719

26 Daniel Horn, Ph.D. Special Consultant World Health Organization Geneva, Switzerland and Director, on leave National Clearinghouse on Smoking and Health, U.S. Cynthia L. Hull, M. Ed. Health Education Consultant Education Service Center, Region XIII Austin, Texas William A. Hunt, Ph.D. Research Scientist The Learning Center American University Washington, D.C. Paul Martin Insel, Ph.D. Senior Health Psychologist Stanford Research Institute Menlo Park, California Jerome H. Jaffe, M.D. Chief, Department of Biological Psychiatry New York State Psychiatric Institute New York, New York Dr. D. Jakovljevic Director Yugoslav Commission for Cooperation with International Health Organizatioris Novi Beograd Yugoslavia Walter G. James, M.A. Vice President Public Education American Cancer Society New York, New York Murray E. Jarvik, M.D. Professor of Psychiatry and Pharmacology University of California Los Angeles, California Daniel J. Joly, M.D., D.P.H. Regional Advisor, Epidemiology of Chronic Diseases Pan American Health Organization World Health Organization Washington, D.C. Allan K. Jonas, B.S.E. Chairman Committee on Tobacco and Cancer American Cancer Society Los Angeles, California Dr. Vladimir Kalaydjiev Vice-President Council for the Development of Human Resources c/o The State Council of the People's Republic of Bulgaria Sofia Bulgaria William B. Kannel, M.D., M.P.H. Co-Director, Framingham Heart Study National Heart and Lung Institute Framingham, Massachusetts Leo A. Kaprio, M.D., D.P.H., F.A.P.H.A. Regional Director World Health Organization Regional Office for Europe Copenhagen Denmark Charles M. Keith, Ph.D. Senior Research Associate Celanese Fibers Company Charlotte, North Carolina Charles J. Kensler, Ph.D. Senior Vice President Professional Operations Arthur D. Little, Inc. Cambridge, Massachusetts Donald C. Kent, M.D. Medical Director Life Extension Institute New York, New York Laura C. Keranen, M.P.H. School of Public Health University of California Berkeley, California Branko Kesic, M.D., Dr. Sc. Professor of Hygiene, Social Medicine, and Epidemiology Andrija Stampar School of Public Health Medical Faculty University of Zagreb Zagreb Yugoslavia Noboru Kimura, M.D. Professor & Director Institute of Cardiovascular Diseases Kurume University Kurume Japan Jerome I. Kleinerman, M.D. Head, Division Pathology Research and Cytrel Project Manager Clinical Pathology St. Luke's Hospital Cleveland, Ohio Dr. Hubert Kius Chemist Austria Tabakwerke AG Vienna Austria Steven A. Kopel, Ph.D. Clinic Coordinator, M.R.F.I.T. Heart Attack Prevention Program Rutgers Medical School Department of Community Medicine Piscataway, New Jersey TIMN 449720

Dr. Hans Kuhn Chief of Research Development Austria'Tabakwerke AG Vienna Austria Roland K. Kunkel Celanese Fibers Company Charlotte, North Carolina Michael K. Kunze, M.D. Assistant Professor Institute of Hygiene, University of Vienna Vienna Austria Joanne B. Lagerson, R.N., M.A. Nurse Specialist in Respiratory Disease The Better Breathing Bureau New York, New York Charles A. LeMaistre, M.D. Chancellor The University of Texas System Austin, Texas Annette Le Meitour-Kaplun, M.A., D.H.E. Editor International Journal of Health Education Geneva Switzerland Claude Lenfant, M.D. Director, Division of Lung Diseases National Heart and Lung Institute Bethesda, Maryland Owen D. Lewis, B.A. Adviser: Policy & Planning (Tobacco) Department of National Health & Welfare Ottawa, Ontario Canada Edward Lichtenstein, Ph.D. Professor of Psychology, Director of Clinical Training University of Oregon Psychology Clinic Eugene, Oregon Sol S. Lifson, M.A., M.P.H. Consultant American Lung Association New York, New York Mary Anita Loos Author, Screenwriter, Santa Monica, California Lawrence D. Longo, M.D. Professor of Physiology and Obstetrics & Gynecology Loma Linda University Department of Perinatal Biology Loma Linda, California Dmitry N. Loransky, M.D. Director Central Institute for Scientific Research in Health Education Moscow U.S.S.R. James B. Losie Executive Director Heart Association, Greater Hartford Hartford, Connecticut B. G. Loveless, B.S. Executive Director American Lung Association-Dallas Area Dallas, Texas Boris Luban-Plozza, M.D. Professor Locarno Switzerland AlastairC. L. Mackie Director General Health Education Council London England Dr. Robert Maronpot American Health Foundation Naylor Dana Institute for Disease Prevention Valhalla, New York A. Helen Martikainen, Dr.Sc. Formerly Chief, Health Education World Health Organization Geneva, Switzerland Bernard Mausner, Ph.D. Professor of Psychology and Chairman, Department of Psychology Beaver College Glenside, Pennsylvania Norman K. McAbee, Jr., M.S. Division Manager Pacific Telephone and Telegraph Beverly Hills, California J. Wayne McFarland, M.D. Associate Secretary Department of Health General Conference of Seventh-day Adventists Washington, D.C. Henry C. McGill, Jr., M.D. Professor of Pathology The University of Texas Health Science Center San Antonio, Texas Gardner C. McMillan, M.D., Ph.D. Associate Director for Etiolbgy of Arteriosclerosis and Hypertension Division of Heart and Vascular Diseases National Heart and Lung Institute Bethesda, Maryland 27 TIMN 449721

Alan S. Meyer, Ph.D. Chief, Evaluation Unit Office of the Regional Director, Department of Health, Education and Welfare New York, New York Robert H. Miller, Ph.D. Program Leader, Tobacco Economic Research Service, U.S. Department Agriculture Washington, D.C. Harry Milt, M.S. Secretary Committee on Tobacco and Cancer American Cancer Society New York, New York Condict Moore, M.D. University of Louisville School of Medicine Dept. of Surgery Health Sciences Center Louisville, Kentucky Dr. N. N. Napalkov Director The Petrov Institute of Cancer Research Leningrad USSR Paul Nettesheim, M.D. Biology Division Oak Ridge National Laboratory Oak Ridge, Tennessee Thomas B. Owen, Ph.D. Assistant Director, Smoking and Health Progratn National Cancer Institute National Institutes of Health Bethesda, Maryland William S. Parker, M.B., Ch.B. District Community Physician, Brighton Health District, East Sussex Area Health Authority Brighton, Sussex England Oglesby Paul, M.D. Vice President of Health Sciences Northwestern University School of Medicine Chicago, Illinois Michae! Pertschuk, B.A., LL.B. Chief Counsel United States Senate Commerce Committee Washington, D.C. Alexander J. Phillips, Ph.D. Director of Public Education Canadian Cancer Society Toronto, Ontario Canada Ovide F. Pomerleau, Ph.D. Director, Center for Behavioral Medicine University of Pennsylvania Hospital Philadelphia, Pennsylvania Lars M. Ramstrom, Ph.D. Director General Michael T. Newhouse, M.D., M.Sc., F.R.C.P. (C) National Smoking and Health Association, NTS Head, Service of Respirology Sweden St. Joseph's Hospital McMaster University Hamilton, Ontario Canada Egbert Niissel, M.D. Professor Clinical Institute for Myocardial Research Heidelberg Federal Republic of Germany Alton Ochsner, Jr., M.D. Member, Board of Directors Louisiana Heart Association Metaire, Louisiana Clifton Read Conference Consultant New York, N.Y. and formerly Vice President for Public Information American Cancer Society Duvur Bhaskara Reddy, M.D. Principal and Professor of Pathology Kurnool Medical College Kurnool India Donald D. Reid, M.D., D.Sc., F.R.C.P. Professor of Epidemiology Martin T. Orne, M.D., Ph.D. Department of Medical Statistics & Epidemiology Professor London School of Hygiene & Tropical Medicine Institute of the Pennsylvania Hospital and London University of Pennsylvania England Philadelphia, Pennsylvania 28 Harold Wayne Richmond, M.D. Corporate Medical Director Cummins Engine Company, Inc. Columbus, Indiana Irving I. Rimer Vice President for Public Information American Cancer Society New York, New York TIMN 449722

Nancy B. Ringle, B.A. Chairman, Education Committee (California Division) American Cancer Society Rancho Palos Verdes, California Gwen W. Rorke, B.A. Chairman, Smoking and Health Committee Canadian Home and School and Parent-Teacher Federation Willowdale, Ontario Canada Geoffrey Rose, D.M., F.R.C.P., F.F.C.M. Professor of Epidemiology and Preventive Medicine St. Mary's Hospital Medical School London England M. A. H. Russell, M.D. Senior Lecturer Addiction Research Unit Institute of Psychiatry Maudsley Hospital London England Ragnar Rylander, M.D. Professor Department of Environmental Hygiene University of Gothenburg Gothenburg Sweden Geno Saccomanno, M.D., Ph.D. Pathologist St. Mary's and Veterans' Hospitals Grand Junction, Colorado George Saunders Coordinator Special Education Projects American Cancer Society California Division Oakland, California Meinrad E. Schar, M.D., M.P.H. Professor Institute of Social and Preventive Medicine University of Zurich Zurich Switzerland Helmut Schievelbein, M.D. Professoc Institute for Clinical Chemistry German Heart Center Munich West Germany Dietrich Schmahl, M.D. Professor Deutsches Krebsforschungszentrum, Institut fur Toxikologie und Chemotherapie Heidelberg West Germany Irwin Schmeltz, Ph.D. Associate Member; Head, Bio-organic Chemistry American Health Foundation Valhalla, New York Roger W. Schmidt Executive Director National Interagency Council on Smoking and Health New York, New York Marvin A. Schneiderman. Ph.D. Associate Director for Field Studies and Statistics, Division of Cancer Cause and Prevention National Cancer Institute Bethesda, Maryland Leonard M. Schuman, M.D. Professor and Director, Division of Epidemiology School of Public Health University of Minnesota Minneapolis, Minnesota Jerome L. Schwartz, D.P.H. Professor of Family Practice School of Medicine University of California Davis, California Friedlieb Seehofer, Sc.D. B.A.T. Cigaretten Fabriken Hamburg Germany Irving J. Selikoff, M.D. Director, Environmental Sciences Laboratory Mount Sinai School of Medicine of the CUNY Mount Sinai Hospital New York, New York William A. Selke, Ph.D. Director of Research Schweitzer Division Kimberly-Clark Corporation Lee, Massachusetts Lloyd A. Shewchuk, Ph.D. Director of Behavioral Sciences American Health Foundation New York, New York Lynn R. Smith Publisher Monticello Times Monticello, Minnesota Herbert Spiegel, M.D. Associate Clinical Professor of Psychiatry College of Physicians & Surgeons Columbia University New York, New York 29 T~N 449723

30 Jeremiah Stamler, M.D. Chairman, Dept. of Community Health and Preventive Medicine Northwestern University The Medical School Chicago, Illinois Jesse L. Steinfeld, M.D. Chairman Department of Medicine Veterans Administration Hospital Long Beach, California and formerly Surgeon General U.S. Public Health Service Jan Stephens, B.A. Supervisor, Bureau of Health Education Montgomery County Combined General Health District County Government Plaza Dayton, Ohio George L. Stewart, M.D. Chairman, Anchorage Council on Smoking and Health Anchorage, Alaska Ian P. Stolerman, Ph.D. University of B irmingham MRC Neuropharmacology Unit, The Medical School Birmingham, England Bruce C. Straits, Ph.D. Associate Professor, Sociology University of California Santa Barbara, California Carl-Edvard Sturkell, Bachelor of Law Justice Katrinehoim District Court Tingshuset Katrineholm Sweden S. Leonard Syme, Ph.D. Professor Epidemiology and Chairman, Dept. of Biomedical and Environmental Health Sciences University of California School of Public Health Berkeley, California Charles Tate, M.D. Dade-Monroe Lung Association Miami, Florida Robert M. Taylor, B.A., M.D., F.R.C.P. (C) Executive Director National Cancer Institute of Canada Toronto, Ontario Canada Luther L. Terry, M.D. President University Associates, Inc. Washington, D.C. and formerly Surgeon General U.S. Public Health Service Professor Gosta Tibblin, M.D. Chief, Dept. of Social and Preventive Medicine University of Umea Umea Sweden Donald Tiggelbeck Manager, Tobacco Industry Sales Pittsburgh Activated Carbon Company Pittsburgh, Pennsylvania Eivind Toft-Nielsen M.sc.e. Editor (and Commissioner) Health Magazine and the Danish Council for Health Education Copenhagen Denmark Bratislav Tomic, M.D., M.P.H. Director, Europa Bureau, I.U.H.E. Institute for Health Education Belgrade Yugoslavia Dr. T. C. TsQ Chief, Tobacco Laboratory, Beltsville Agricultural Research Center Agricultural Research Service U.S. Department of Agriculture Beltsville, Maryland Richard W. D. Turner, M.D., F.R.C.P. Senior Research Fellow in Preventive Cardiology University of Edinburgh Edinburgh Scotland Benjamin L. Van Duuren, Sc.D. Professor of Environmental Medicine New York University Medical Center New York, New York Karl R. Waernberg President Swedish Tobacco Company Stockholm Sweden TIMN 449724

F. R. Wake, Ph.D. Professor of Psychology St. Patrick's College Carleton University Ottawa, Ontario Canada Nicholas J. Wald, M.D., M.R.C.P. Lecturer in Medicine DHSS Cancer Epidemiology & Clinical Trials Unit Dept. of the Regius Professor of Medicine Radcliffe Infirmary Oxford England Leo K. Widmer, M.D., D.Sc. Division of Angiology, Head, Dept. of Internal Medicine Kantonsspital Basle Switzerland Lars Wilhelmsen, M.D. Associate Professor Medical Department Sahlgren's Hospital Goteborg Sweden Peter D. Wood, D.Sc. Adjunct Professor of Medicine Stanford University School of Medicine Stanford, California A. P. Woudenberg, M.D. Regional Officer in Health Education and Social Sciences World Health Organization Regional Office for Europe Copenhagen, Denmark John P. Wyatt, M.D. Director, Tobacco Health Research Institute University of Kentucky Lexington, Kentucky Ernst L. Wynder, M.D. President American Health Foundation New York, New York Alfred Yarrow, M.B., Ch.B., D.P.H., F.F.C.M. Senior Medical Officer, Department of Health & Social Security " London England Bryan F. Zilkey, Ph.D. Research Station Canada Agriculture Delhi, Ontario Canada 31 TIMN 449725

I t TIMN 449726